Generation Bio to Present at the 2024 TD Cowen Health Care Conference
February 27 2024 - 6:59AM
Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating
genetic medicines for people living with rare and prevalent
diseases, announced that Geoff McDonough, M.D., president and chief
executive officer, will present at the 2024 TD Cowen Health Care
Conference on Tuesday, March 5, 2024 at 9:10 a.m. ET in Boston.
A live webcast of the presentation will be
available on the investor section of the company’s website at
investors.generationbio.com. A replay will be available there for
30 days following the event.
About Generation Bio
Generation Bio is innovating non-viral genetic
medicines to provide durable and redosable treatments for hundreds
of millions of patients living with rare and prevalent diseases.
The company is developing two distinct and complementary platforms:
a potent, highly selective cell-targeted lipid nanoparticle (ctLNP)
delivery system and a novel immune-quiet DNA (iqDNA) cargo produced
by a scalable capsid-free manufacturing process that uses
proprietary cell-free rapid enzymatic synthesis (RES). With these
platforms, Generation Bio aims to develop the next wave of
non-viral genetic medicines to support its mission to extend the
reach of genetic medicine to more people living with more diseases,
around the world.
For more information, please visit
www.generationbio.com.
Investors and Media
Contact Maren Killackey Generation
Bio mkillackey@generationbio.com 857-371-4638
Generation Bio (NASDAQ:GBIO)
Historical Stock Chart
From May 2024 to Jun 2024
Generation Bio (NASDAQ:GBIO)
Historical Stock Chart
From Jun 2023 to Jun 2024